Contest Catch the Monkey 06.07.2024
Issue 5 predictions
The first 5 predictions you issue after the contest starts automatically take part in the contest
Show more

Win
Keep an eye on the ranking to see if you're amongst the winners. The top spots are rewarded with attractive prizes.
Currently 25 participants. The winner receives a €30 Amazon voucher.
Show moreThe winner of our stockpicking contest Catch the Monkey 06.07.2024 is michaelkr with a performance of 23.318% ahead of Bankster. With a performance of 3.137% KongVestor only managed to reach position 25.
We discuss all securities, matching the rule For 5 securities, where you also told the community the pros and cons you get 1% extra performance
The most predictions written for this stockpicking contest were for NVIDIA Corp., followed by Apple Inc. and Nokia Corp.. 27 contestants picked NVIDIA Corp., followed by 20 predictions for Apple Inc. and 12 for Nokia Corp.. michaelkr had the best individual performance with the prediction Buy Annovis Bio Inc., followed by Ackermann with Buy G1 Therapeutics and Bankster with Buy G1 Therapeutics. The prediction Buy Annovis Bio Inc. achieved a performance of 101.501%. 72.607% are in the books for the prediction Buy G1 Therapeutics, and 72.607% for Buy G1 Therapeutics.
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| HP Inc. | buy | €32.80 | -2.546% |
| Northern Data AG | buy | €28.80 | -34.514% |
| Broadcom Ltd. | buy | €1,482.0 | 6.019% |
| Hewlett Packard Enterprise Co | buy | €19.58 | -3.198% |
| Continental AG | buy | €61.12 | 0.458% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Under Armour Inc. A | buy | €6.35 | -6.975% |
| Levi Strauss & Co. | buy | €21.69 | -18.626% |
| Leidos Holdings Inc. | buy | €137.05 | -2.043% |
| Golar LNG Ltd. | buy | €28.70 | 0.871% |
| Brinker International Inc. | buy | €71.00 | -7.747% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Scinai Immunotherapeutics Ltd. | sell | €3.12 | -8.974% |
| Cardiol Therapeutics Inc. | buy | €1.85 | -1.620% |
| G1 Therapeutics | sell | €1.94 | 22.348% |
| Savara Inc. | sell | €3.52 | 12.500% |
| Ocugen Inc. | sell | €1.18 | 33.418% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| G1 Therapeutics | buy | €2.25 | -15.733% |
| Fibrogen Inc. | buy | €1.04 | -36.782% |
| Annovis Bio Inc. | buy | €5.60 | 33.929% |
| Effector Therapeutics Inc. | buy | €0.29 | -41.986% |
| Atos SE | buy | €1.06 | -28.665% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Molecular Partners AG | sell | €6.60 | -7.576% |
| Adicet Bio Inc. | buy | €1.42 | -25.388% |
| Vaccitech Plc | sell | €1.19 | 6.723% |
| Serina Therapeutics Inc. | sell | €3.40 | 92.647% |
| Scinai Immunotherapeutics Ltd. | sell | €3.30 | -12.121% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Apple Inc. | buy | €195.18 | 7.007% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Levi Strauss & Co. | buy | €18.00 | -1.944% |
| Nike Inc. B | buy | €74.01 | -6.023% |
-
GrowthVolatility32
-
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Volkswagen AG VZO | buy | €106.70 | 0.609% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Finmeccanica | buy | €22.31 | 1.300% |
| Rheinmetall AG | buy | €504.00 | -1.568% |
| Apple Inc. | buy | €204.70 | 1.979% |
-
BondsIndex69
-
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Apple Inc. | buy | €204.70 | 1.929% |
Top Performer
| Prediction | Security | User | Perf. (%) |
|---|---|---|---|
| B | Annovis Bio Inc. | michaelkr | 101.501% |
| B | G1 Therapeutics | Ackermann | 72.607% |
| B | G1 Therapeutics | Bankster | 72.607% |
| B | VivoPower International PLC | ReynadJ | 53.425% |
| B | HelloFresh SE | blaugold | 37.321% |
| Prediction | Security | User | Perf. (%) |
|---|---|---|---|
| S | Carisma Therapeutics Inc. | blaugold | -40.975% |
| S | Clearmind Medicine Inc. | quelbe60 | -32.157% |
| S | Atos SE | quelbe60 | -23.318% |
| S | Chewy Inc | fenjal | -22.767% |
| S | Regulus Therapeutics Inc. | Lokrim | -13.472% |
Comments
The comment is under review
The comment is under review



